E G Bovill - JoVE Visualize

Showing results (81-90 of 100) with videos related to

Pageof 10

Sort By:

Archives of Pathology & Laboratory Medicine|January 1, 1993

Performance characteristics of fibrinogen assays. Results of the College of American Pathologists Proficiency Testing Program 1988-1991E G Bovill, J McDonagh, D A Triplett, et al.

Thrombosis and Haemostasis|February 24, 2001

Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindredB T Scott, E G Bovill, P W Callas, et al.

Journal of Thrombosis and Haemostasis : JTH|May 18, 2011

Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindredM E Meltzer, S J Hasstedt, C Y Vossen, et al.

American Heart Journal|March 1, 1996

Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B InvestigatorsR C Becker, C P Cannon, R P Tracy, et al.

Journal of Thrombosis and Haemostasis : JTH|February 8, 2013

Genetic variants associated with protein C levelsC Y Vossen, B P Koeleman, S J Hasstedt, et al.

American Heart Journal|June 1, 1990

Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1995

Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health StudyR P Tracy, E G Bovill, D Yanez, et al.

American Heart Journal|March 1, 1996

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplastyA J Smith, R E Holt, J B Fitzpatrick, et al.

Circulation|April 1, 1995

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.

Journal of the American College of Cardiology|March 21, 1998

Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.

Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:

Pageof 10

Archives of Pathology & Laboratory Medicine|January 1, 1993

Performance characteristics of fibrinogen assays. Results of the College of American Pathologists Proficiency Testing Program 1988-1991E G Bovill, J McDonagh, D A Triplett, et al.

Thrombosis and Haemostasis|February 24, 2001

Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindredB T Scott, E G Bovill, P W Callas, et al.

Journal of Thrombosis and Haemostasis : JTH|May 18, 2011

Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindredM E Meltzer, S J Hasstedt, C Y Vossen, et al.

American Heart Journal|March 1, 1996

Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B InvestigatorsR C Becker, C P Cannon, R P Tracy, et al.

Journal of Thrombosis and Haemostasis : JTH|February 8, 2013

Genetic variants associated with protein C levelsC Y Vossen, B P Koeleman, S J Hasstedt, et al.

American Heart Journal|June 1, 1990

Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormalityR C Becker, J M Corrao, E G Bovill, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1995

Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health StudyR P Tracy, E G Bovill, D Yanez, et al.

American Heart Journal|March 1, 1996

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplastyA J Smith, R E Holt, J B Fitzpatrick, et al.

Circulation|April 1, 1995

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.

Journal of the American College of Cardiology|March 21, 1998

Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.

Pageof 10